2022 AUA Recaps : Episode 1

Video

Dr. Spiess on key penile and testis cancer research from AUA 2022

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      In this video, Philippe Spiess, MD, MS, FACS, recaps several presentations from the 2022 American Urological Association Annual Meeting in New Orleans, Louisiana. Spiess is a genitourinary oncologist and the assistant chief of surgical services at Moffitt Cancer Center in Tampa, Florida.

      Among the abstracts discussed are:

      1. PD51-06 (Konneh et al): Evaluation of Mir-371a-3p Performance in Detecting Seminomatous Testicular Cancer Metastases

      2. MP46-02 (Lafin et al): Refinement of the Serum miR-371a-3p Test for the Detection of Chemotherapy-naive Minimal Residual Testicular Cancer

      3. MP46-09 (Churchill et al): Does time to dynamic sentinel lymph node biopsy affect recurrence-free survival in penile squamous cell carcinoma?

      4. MP46-11 (Nazzani et al): Bilateral inguinal lymphnode dissection versus inguinal lymphnode dissection and dynamic sentinel node biopsy in N1 squamous cell carcinoma of the penis

      Related Content
      © 2025 MJH Life Sciences

      All rights reserved.